Literature DB >> 14332163

ALDOSTERONE SECRETION RATE IN CONGENITAL ADRENAL HYPERPLASIA. A DISCUSSION OF THE THEORIES ON THE PATHOGENESIS OF THE SALT-LOSING FORM OF THE SYNDROME.

A KOWARSKI, J W FINKELSTEIN, J S SPAULDING, G H HOLMAN, C J MIGEON.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ADRENOGENITAL SYNDROME; ALDOSTERONE; ALDOSTERONE ANTAGONISTS; CHILD; CORTISONE, THERAPEUTIC; DESOXYCORTICOSTERONE; ENDOCRINOLOGY; HYDROXYLASES; METABOLISM, INBORN ERRORS; NATRIURESIS; PATHOLOGY; SECRETION

Mesh：

Substances：

Year:  1965        PMID： 14332163      PMCID： PMC292632          DOI： 10.1172/JCI105257

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  23 in total

1.  Aldosterone excretion in virilizing adrenal hyperplasia.

Authors:  R M BLIZZARD; G W LIDDLE; C J MIGEON; L WILKINS
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  EFFECT OF VARIOUS PREPARATIONS OF HUMAN GROWTH HORMONE ON ALDOSTERONE SECRETION RATE OF HYPOPITUITARY DWARFS.

Authors:  J W FINKELSTEIN; A KOWARSKI; J S SPAULDING; C J MIGEON
Journal:  Am J Med       Date:  1965-04       Impact factor: 4.965

3.  Double isotope derivative assay of aldosterone in biological extracts.

Authors:  B KLIMAN; R E PETERSON
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

4.  The metabolic effects of progesterone in man: dose response relationships.

Authors:  R L LANDAU; K LUGIBIHL; D M BERGENSTAL; D F DIMICK
Journal:  J Lab Clin Med       Date:  1957-10

5.  Steroid isolation studies in congenital adrenal hyperplasia.

Authors:  D K FUKUSHIMA; T F GALLAGHER
Journal:  J Biol Chem       Date:  1957-11       Impact factor: 5.157

6.  The metabolic effects of progesterone in man.

Authors:  R L LANDAU; D M BERGENSTAL; K LUGIBIHL; M E KASCHT
Journal:  J Clin Endocrinol Metab       Date:  1955-10       Impact factor: 5.958

7.  [Increase aldosterone excretion in congenital adrenogenital syndrome; pathogenesis of the syndrome].

Authors:  A PRADER; A SPAHR; R NEHER
Journal:  Schweiz Med Wochenschr       Date:  1955-11-05

8.  Further studies on the treatment of congenital adrenal hyperplasia with cortisone. IV. Effect of cortisone and compound B in infants with disturbed electrolyte metabolism.

Authors:  J F CRIGLER; S H SILVERMAN; L WILKINS
Journal:  Pediatrics       Date:  1952-10       Impact factor: 7.124

9.  The effects of adrenocorticotropic hormone and cortisone in the adrenogenital syndrome associated with congenital adrenal hyperplasia: an attempt to explain and correct its disordered hormonal pattern.

Authors:  F C BARTTER; F ALBRIGHT; A P FORBES; A LEAF; E DEMPSEY; E CARROLL
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

10.  Electrolyte balances in a male infant with adrenocortical insufficiency and virilism; the effect of desoxycorticosterone acetate and salt therapy with special reference to potassium.

Authors:  H L BARNETT; H McNAMARA
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808
View more
  7 in total

1.  Evaluation of deficiency of 21-hydroxylation in patients with congenital adrenal hyperplasia.

Authors:  O M Galal; B T Rudd; N M Drayer
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

2.  Adreno-genital syndrome.

Authors:  I C Verma; M Singh; O P Ghai
Journal:  Indian J Pediatr       Date:  1969-09       Impact factor: 1.967

3.  Aldosterone excretion in normal children and in children with adrenal hyperplasia.

Authors:  M I New; B Miller; R E Peterson
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

4.  Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).

Authors:  I S Salti; M Stiefel; J L Ruse; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1969-07-12       Impact factor: 8.262

5.  Influence of breast feeding on the clinical features of salt-losing congenital adrenal hyperplasia.

Authors:  J A Curtis; J D Bailey
Journal:  Arch Dis Child       Date:  1983-01       Impact factor: 3.791

6.  Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone.

Authors:  D J Sutherland; J L Ruse; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1966-11-26       Impact factor: 8.262

7.  Aldosterone hypersecretion in "non-salt-losing" congenital adrenal hyperplasia.

Authors:  F C Bartter; R I Henkin; G T Bryan
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.